Kevin E O'Grady Selected Research

Buprenorphine (Subutex)

12/2019	Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.
1/2019	A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.
10/2018	Pharmacotherapy for opioid addiction in community corrections.
1/2018	Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
1/2018	Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
6/2017	Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
11/2015	Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners.
10/2015	Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.
10/2015	Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.
1/2015	Buprenorphine Treatment for Probationers and Parolees.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin E O'Grady Research Topics

Disease

31	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2008
27	Opioid-Related Disorders (Opiate Addiction) 11/2021 - 09/2008
12	Neonatal Abstinence Syndrome 01/2020 - 07/2005
6	Heroin Dependence (Heroin Abuse) 09/2014 - 01/2006
5	Alcoholism (Alcohol Abuse) 02/2020 - 02/2011
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2017 - 04/2011
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2011 - 02/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 05/2011 - 11/2007
2	Marijuana Use 01/2020 - 01/2013
2	HIV Infections (HIV Infection) 12/2019 - 07/2010
2	Tobacco Use Disorder (Nicotine Dependence) 08/2013 - 01/2013
1	Depressive Disorder (Melancholia) 10/2017
1	Opiate Overdose 06/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Gambling (Pathological Gambling) 04/2015
1	Drug Misuse 08/2014
1	Marijuana Abuse (Cannabis Abuse) 07/2014
1	Alcohol-Related Disorders 03/2014
1	Birth Weight (Birth Weights) 01/2014
1	Weight Gain 05/2013
1	Infections 11/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2012
1	Congenital Abnormalities (Deformity) 09/2011
1	HIV Seropositivity 09/2011
1	Acute Pain 06/2011
1	Lethargy 11/2010
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2009
1	Mood Disorders (Mood Disorder) 01/2009

Drug/Important Bio-Agent (IBA)

28	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 07/2005
25	Opioid Analgesics (Opioids)IBA 12/2020 - 07/2005
24	Buprenorphine (Subutex)FDA LinkGeneric 12/2019 - 07/2005
23	Pharmaceutical PreparationsIBA 01/2021 - 11/2007
12	nasIBA 01/2020 - 07/2005
9	Heroin (Diamorphine)IBA 01/2020 - 07/2010
8	Cocaine (Cocaine HCl)IBA 01/2020 - 04/2011
5	Naltrexone (ReVia)FDA LinkGeneric 11/2021 - 01/2012
5	Illicit Drugs (Recreational Drugs)IBA 01/2016 - 02/2008
5	Morphine (MS Contin)FDA LinkGeneric 01/2014 - 12/2010
4	Naloxone Drug Combination Buprenorphine FDA Link 01/2018 - 01/2013
3	Nicotine FDA Link 04/2015 - 07/2014
2	Analgesics (Analgesic Drugs)IBA 06/2011 - 03/2010
1	Caffeine (No Doz)FDA LinkGeneric 10/2017
1	Antidepressive Agents (Antidepressants)IBA 10/2017
1	tacedinaline (CI 994)IBA 08/2013
1	tyramine-deoxysorbitolIBA 08/2013
1	BenzodiazepinesIBA 01/2012
1	N 30IBA 01/2009
1	Prescription DrugsIBA 01/2008

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 10/2018 - 11/2010
7	Length of Stay 01/2014 - 01/2009
3	Patient Readmission 01/2022 - 01/2018
2	Therapeutics 01/2020 - 01/2013
2	Duration of Therapy 09/2013 - 12/2010
1	Ambulatory Care (Outpatient Care) 01/2019
1	Analgesia 05/2013
1	Self Medication 09/2009
1	Condoms (Condom) 08/2009